Newsroom
Latest News
Washington, DC – Congresswoman Diana DeGette (D-CO) today hailed the decision by the U.S. Department of Housing and Urban Development to provide a $30 million grant that she helped secure for affordable housing and neighborhood revitalization in Denver.
Thank you, Mr. Chairman.
This is the last EPA hearing this Committee will hold with the Obama Administration.
The EPA has not always received the support it deserves from Congress. Even as the Agency has worked to fulfill its mission of protecting human health and the environment, it has faced criticism and attack.
Despite sometimes unfair opposition, EPA has commendably responded to unprecedented environmental challenges facing the country and the planet. I would like to highlight some of the agency’s accomplishments. Under the Obama Administration:
With passage in the House of Representatives of the 21st Century Cures Act that I co-authored with Michigan Republican Rep. Fred Upton, we’re just two steps away from a major victory for U.S. research into causes and treatments for disease. The next few days will decide its fate as the U.S. Senate prepares to vote.
More than 700 groups representing patients, health care providers, researchers and others have voiced support for the bill – as has the White House, which provided its enthusiastic endorsement before and just after the House approved it by a vote of 392 to 26.
WASHINGTON — The House overwhelmingly passed a far-reaching measure on Wednesday to increase funding for research into cancer and other diseases, address weaknesses in the nation’s mental health systems and help combat the prescription drug addictions that have bedeviled nearly every state.
The bill, known as the 21st Century Cures Act, also makes regulatory changes for drugs and medical devices, which critics argue lower standards to potentially perilous levels.
In the coming days, the Republican-controlled Congress is likely to approve legislation that will invest more than $6 billion in public health and medical research over the next decade. It will expedite basic research into new medical devices and disease-curing drugs. It will reform mental health treatment and fund research into brain injuries and Alzheimer’s. The bill authorizes $1 billion to combat the opioid epidemic and $1.8 billion for Vice President Joe Biden’s “moonshot” project to cure cancer.
WASHINGTON — A bill that would make sweeping changes to the medical research field passed the U.S. House on Wednesday, getting U.S. Rep. Diana DeGette of Denver that much closer to securing a win for her top legislative priority.
The 392-26 vote was a larger margin than the 344-77 vote that backed a 2015 version of the bill, but came as some Senate Democrats and progressive groups raised concerns over whether the measure does too much to help drug and medical-device companies.
WASHINGTON, DC – Vital innovations in biomedical research are within reach, potentially saving countless lives, with the House about to debate its final version of the bipartisan 21st Century Cures Act, Congresswoman Diana DeGette (D-CO) said.
“This is a watershed moment for patients, their loved ones and health care professionals across the United States,” DeGette said. “We’re bringing hope to millions of people suffering from cancer, Alzheimer’s disease, diabetes and a host of other ailments.”
Washington, D.C. – U.S. Reps. Diana DeGette (CO-01) and Louise Slaughter (NY-25), co-chairs of the House Pro-Choice Caucus, called on congressional leaders to disband the Select Panel ahead of a vote expected Thursday on a privileged resolution that would provide an additional $800,000 in taxpayer dollars for the panel, which has aggressively targeted women’s health providers and the scientific community. House Republicans are now on course to spend more than $1.5 million funding this partisan attack on women’s health.
Denver, CO – With families in Colorado and across the country about to hit the roads for the holiday season, Congresswoman Diana DeGette (D-CO) has renewed her push for authorities to overhaul an outdated federal standard governing car seatback safety and require that the government be notified whenever death or injuries from seatback collapses occur.